Datasheet
Revision date: 24/05/2016 Revision: 0
Electrolube IPA Cleaning Wipes x100
1,2-Benzisothiazol-3(2H)-one <1%
CAS number: 2634-33-5 EC number: 220-120-9
M factor (Acute) = 1
Classification
Acute Tox. 4 - H302
Skin Irrit. 2 - H315
Eye Dam. 1 - H318
Skin Sens. 1 - H317
Aquatic Acute 1 - H400
Reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC
no. 247-500-7] and 2-methyl-2H -isothiazol-3-one [EC no.
220-239-6] (3:1)
<1%
CAS number: 55965-84-9
M factor (Acute) = 10 M factor (Chronic) = 1
Classification
Acute Tox. 3 - H301
Acute Tox. 3 - H311
Acute Tox. 2 - H330
Skin Corr. 1B - H314
Eye Dam. 1 - H318
Skin Sens. 1 - H317
Aquatic Acute 1 - H400
Aquatic Chronic 1 - H410
The full text for all hazard statements is displayed in Section 16.
SECTION 4: First aid measures
4.1. Description of first aid measures
General information Get medical attention if any discomfort continues. Show this Safety Data Sheet to the medical
personnel.
Inhalation Move affected person to fresh air and keep warm and at rest in a position comfortable for
breathing. Maintain an open airway. Loosen tight clothing such as collar, tie or belt. When
breathing is difficult, properly trained personnel may assist affected person by administering
oxygen. Get medical attention. Place unconscious person on their side in the recovery
position and ensure breathing can take place.
Ingestion Rinse mouth thoroughly with water. Give a few small glasses of water or milk to drink. Stop if
the affected person feels sick as vomiting may be dangerous. Never give anything by mouth
to an unconscious person. Place unconscious person on their side in the recovery position
and ensure breathing can take place. Keep affected person under observation. Get medical
attention.
Skin contact Rinse with water.
Eye contact Rinse with water. Do not rub eye. Remove any contact lenses and open eyelids wide apart.
Get medical attention if any discomfort continues.
Protection of first aiders First aid personnel should wear appropriate protective equipment during any rescue.
4.2. Most important symptoms and effects, both acute and delayed
3/
15










